These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29804061)

  • 1. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
    Kunadian V; Chan D; Ali H; Wilkinson N; Howe N; McColl E; Thornton J; von Wilamowitz-Moellendorff A; Holstein EM; Burns G; Fisher A; Stocken D; De Soyza A;
    BMJ Open; 2018 May; 8(5):e020713. PubMed ID: 29804061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial.
    Kunadian V; Wilson N; Stocken DD; Ali H; McColl E; Burns G; Howe N; Fisher A; De Soyza A
    ERJ Open Res; 2019 Jul; 5(3):. PubMed ID: 31403053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for the air purification for eosinophilic COPD study (APECS): a randomised controlled trial of home air filtration by HEPA.
    Saeed MS; Denoncourt CM; Chao IA; Schortmann S; Nassikas NJ; Synn AJ; Koutrakis P; Coull BA; Kang CM; Wolfson JM; Ferguson ST; Rebuli ME; Jaspers I; Liu JP; Greco KF; Phipatanakul W; Rice MB
    BMJ Open; 2024 Jan; 14(1):e074655. PubMed ID: 38238060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD.
    Martin A; Hancox RJ; Chang CL; Beasley R; Wrobel J; McDonald V; Dobler CC; Yang IA; Farah CS; Cochrane B; Hillis GS; Scowcroft CP; Aggarwal A; Di Tanna GL; Balicki G; Galgey S; Jenkins C
    BMJ Open; 2021 Aug; 11(8):e053446. PubMed ID: 34452971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design for a randomised controlled trial to explore the modality and mechanism of Tai Chi in the pulmonary rehabilitation of chronic obstructive pulmonary disease.
    Fu JJ; Min J; Yu PM; McDonald VM; Mao B
    BMJ Open; 2016 Aug; 6(8):e011297. PubMed ID: 27491669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
    Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.
    Gelinas JC; Lewis NC; Harper MI; Melzer B; Agar G; Rolf JD; Eves ND
    Exp Physiol; 2017 Nov; 102(11):1548-1560. PubMed ID: 28857336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
    Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of transcutaneous electrical nerve stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: randomised controlled trial.
    Öncü E; Zincir H
    J Clin Nurs; 2017 Jul; 26(13-14):1834-1844. PubMed ID: 27325551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
    Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
    Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
    Bhatt SP; Dransfield MT; Cockcroft JR; Wang-Jairaj J; Midwinter DA; Rubin DB; Scott-Wilson CA; Crim C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():351-365. PubMed ID: 28176907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Quint JK
    BMJ Open; 2018 Nov; 8(11):e024736. PubMed ID: 30429149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
    Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
    J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of targeted nutrient supplementation on physical activity and health-related quality of life in COPD: study protocol for the randomised controlled NUTRECOVER trial.
    Beijers RJ; van Iersel LEJ; Schuurman LT; Hageman RJJ; Simons SO; van Helvoort A; Gosker HR; Schols AM
    BMJ Open; 2022 Mar; 12(3):e059252. PubMed ID: 35296491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.